Regulations.gov document
Reference 8 re: Agency Information Collection Activities; Submission for Office of…
Supporting & Related Material · FDA-2020-N-1307 · posted Sep 15, 2021
Key facts
| Document ID | FDA-2020-N-1307-0017 |
|---|---|
| Title | Reference 8 re: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2020-N-1307 |
| Posted | Sep 15, 2021 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: